Charlie's Holdings Reports 204.4% Revenue Growth to $4.8 Million in Latest Quarter

Charlie's Holdings, Inc. reported significant financial growth in its latest quarterly results, with product revenue for the three months ending March 31, 2026, reaching approximately $4.8 million, a 204.4% increase from $1.6 million in the same period last year. The company's gross profit also saw a substantial rise, climbing to $1.2 million from $386,000, driven primarily by increased sales of its nicotine-based and alternative nicotine products, particularly the SBX disposable vapor products, which are not subject to FDA review. Despite this revenue growth, Charlie's Holdings incurred a loss from operations of $975,000, slightly higher than the $879,000 loss reported in the previous year.

The company's operational expenses increased significantly, with total operating costs rising to $2.2 million from $1.3 million, reflecting higher general and administrative expenses, sales and marketing costs, and research and development investments. General and administrative expenses alone increased by 60% to $1.7 million, attributed to higher wages, professional fees, and other operational costs. The company also reported a reduction in interest expenses, which fell to $75,000 from $241,000, contributing to a net loss of $1.05 million, down from $1.27 million in the prior year.

In terms of strategic developments, Charlie's Holdings has focused on enhancing its product offerings and market presence. The company launched new disposable vape products under the SBX brand and is actively pursuing regulatory approvals for its nicotine product portfolio. Additionally, the company has entered into a licensing agreement with IKE Tech LLC to develop an AI-powered age-gating system for its products, which could provide a competitive advantage in the regulatory landscape. The company is also exploring potential partnerships to monetize its remaining PMTA-submitted products, which could further enhance its market position.

Operationally, Charlie's Holdings reported an increase in working capital to $4.8 million as of March 31, 2026, up from $3.1 million at the end of 2025. The company’s cash balance decreased to $640,000, reflecting ongoing investments in growth and operational activities. The total employee headcount has also increased to support the company's expansion efforts. Looking ahead, management remains optimistic about the company's ability to navigate regulatory challenges and capitalize on growth opportunities, particularly in the non-combustible and alternative alkaloid product segments.

Overall, Charlie's Holdings is positioning itself for future growth through strategic product development, regulatory compliance, and market expansion, while managing its financial performance amid ongoing challenges in the vapor products industry. The company believes it is adequately capitalized to support its operations and meet obligations over the next twelve months, despite the losses reported in the latest quarter.